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httpPostdischarge outcomes after endovascular
abdominal aortic aneurysm repair
Prateek K. Gupta, MD,a Travis L. Engelbert, MD,a Bala Ramanan, MBBS,b Xiang Fang, PhD,c
Dai Yamanouchi, MD,a John R. Hoch, MD,a and Charles W. Acher, MD,a Madison, Wisc; and Omaha, Neb
Objective: Perioperative outcomes after endovascular repair (EVAR) of abdominal aortic aneurysms (AAA) have been
rigorously studied; however, inpatient and postdischarge outcomes have not been separately analyzed. The objective of
this study was to examine postdischarge 30-day outcomes after elective EVAR.
Methods: Patients who underwent an elective EVAR for AAA (n[ 11,229) were identiﬁed from the American College of
Surgeons 2005-2010 National Surgical Quality Improvement Project database. Univariable and multivariable logistic
regression analyses were performed.
Results: The median length of hospital stay was 2 days (interquartile range, 1-3 days). Overall 30-day mortality was 1.0%
(n [ 117), with 31% (n [ 36) of the patients dying after discharge. Overall 30-day morbidity was 10.7% (n [ 1204),
with 40% (n[ 500) of the morbidities being postdischarge. The median time of death and complication was 9 and 3 days,
respectively, after surgery. Eighty-eight percent of the wound infections (n[ 205 of 234), 33% of pneumonia (n[ 44 of
133), and 55% of venous thromboembolism (n [ 36 of 65) were postdischarge. Multivariable analyses showed age,
congestive heart failure, admission from nursing facility, postoperative pneumonia, myocardial infarction, and renal
failure were independently associated with postdischarge mortality, and peripheral arterial disease, female gender,
previous cardiac surgery, age, smoking, and diabetes with postdischarge morbidity (P < .05 for all).
Conclusions: Patient characteristics associated with a higher risk for postdischarge adverse events after EVAR were
identiﬁed. Whether improved predischarge surveillance and close postdischarge follow-up of identiﬁed high-risk patients
will further improve 30-day outcomes after EVAR needs to be prospectively studied. (J Vasc Surg 2014;59:903-8.)In the United States, 60% of aortic aneurysms are
repaired by endovascular techniques, and this number is
increasing every year.1 The widespread use of the endovas-
cular approach is largely due to its favorable perioperative
morbidity and mortality compared with open repair.2,3
During the last decade, postoperative morbidity and
mortality rates after endovascular aortic aneurysm repair
(EVAR) have improved.2,3 Given the short index hospital
stay after EVAR, further improvement in outcomes will
largely depend on prevention, early identiﬁcation, and
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://dx.doi.org/10.1016/j.jvs.2013.10.057Our objective was to examine postdischarge 30-day
outcomes after elective EVAR using the nationally vali-
dated, clinical, American College of Surgeons National
Surgical Quality Improvement Program (NSQIP) data
set. Knowledge of these outcomes may lead to develop-
ment of strategies for early identiﬁcation and close
follow-up of at-risk patients and thus, possible prevention
of postdischarge complications and readmissions.METHODS
Data set.Data were extracted from the 2005-2010
NSQIP Participant Use Data Files,4 which are multi-
center, prospective databases with 121 (year 2005 to
2006), 183 (year 2007), 211 (year 2008), 237 (year
2009), and 258 (year 2010) participating academic and
community United States hospitals, with data being
collected on >250 perioperative variables. In NSQIP,
a participating hospital’s surgical clinical reviewer (SCR)
captures data using a variety of methods, one of which is
medical record abstraction. Events occurring after hospital
discharge are identiﬁed using comprehensive strategies.5 In
addition to examining inpatient medical records and
outpatient charts, a minimum of three attempts to contact
the patient by telephone or mail are made by the SCR to
ensure accurate documentation of postdischarge events. If
no response is obtained, the Social Security Death Index
and the National Obituary Archives are queried to inves-
tigate the potential of a death. Hospitals are required to
provide complete 30-day follow-up on at least 95% of the
sampled patients.5903
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formulated by a committee. To ensure the data collected are
of a high quality, NSQIP has developed different training
mechanisms for the SCR and conducts an inter-rater reli-
ability audit of participating sites.4 Inter-rater reliability
audits show that overall disagreement rates on variables
was 1.56% (>140,000 audited ﬁelds) in 2008.6 The
processes of SCR training, inter-rater reliability auditing,
data collection, and samplingmethodology have been previ-
ously described in detail.4,7,8
Patients. Patients undergoing elective EVAR in the
NSQIP data sets were identiﬁed using the Current Proce-
dural Terminology code (American Medical Association,
Chicago, Ill) for the procedure in combination with an
International Classiﬁcation of Diseases, 9th Revision, Clin-
ical Modiﬁcation diagnosis code of AAA. To eliminate any
potentially nonelective patients and to improve generaliz-
ability, the following exclusion criteria were also applied:
impaired sensorium, coma, tumor involving the central
nervous system, hemiplegia/hemiparesis, paraplegia/para-
paresis, quadriplegia/quadriparesis, disseminated cancer,
chemotherapy #30 days, radiotherapy #90 days, preoper-
ative do-not-resuscitate status, ventilator requirement be-
fore surgery, ascites, esophageal varices, acute renal failure
before operation, preoperative transfusion of >4 units
packed red blood cells, emergency case classiﬁcation,
preoperative systemic sepsis #48 hours, contaminated/
dirty wound class, cases with a simultaneous procedure,
and previous operation #30 days. Preoperative data ob-
tained included demographic, lifestyle, comorbidity, func-
tional status, and other variables. NSQIP studies outcomes
through 30 days after the index operation.
Outcome. The primary outcome of interest was post-
discharge 30-day mortality. The secondary outcome was
postdischarge 30-day overall morbidity, which includes any
of wound infection, organ space infection, urinary tract
infection, wound dehiscence, pneumonia, reintubation,
pulmonary embolism, deep venous thrombosis, failure to
wean from ventilator #48 hours, renal insufﬁciency, renal
failure requiring dialysis, stroke, coma, peripheral nerve
deﬁciency, cardiac arrest, myocardial infarction, graft
complication, transfusion >4 units of red blood cells, and
sepsis.
Statistical analysis.The Pearson c2 or Fisher exact test
was used to perform univariable analysis for categoric vari-
ables and the t-test was used for continuous variables. Step-
wise multiple logistic regression analyses were performed to
assess factors associated with the primary and secondary
study outcomes. Preoperative and intraoperative variables,
as well as in-hospital complications and length of stay
(LOS), were considered as independent variables for the
regression analysis. Only variables with a P value of <.1 on
univariable analysis were included in the multivariable
analysis. Interactions were assessed for multicollinearity and
none found. Statistical analyses were performed using SAS
9.2 software (SAS Institute, Cary, NC). A P value of <.05
was considered signiﬁcant.RESULTS
Of the 11,229 patients (82.7% men) who underwent
an elective EVAR, median age was 75 years. The demo-
graphic characteristics, comorbidities, and laboratory values
are listed in Table I.
The 30-day mortality was 1.0% (n ¼ 117), with 31%
(n ¼ 36) of deaths occurring after discharge from the
hospital. The overall 30-day morbidity was 10.7% (n ¼
1204), with 40% (n ¼ 500) of these occurring postdis-
charge. Table II lists the postoperative complications.
More than 90% of patients (n¼ 456 of 500) who devel-
oped a postdischarge complication did not experience an
inpatient morbidity. However, the occurrence of a compli-
cation in the inpatient setting increased the likelihood of
developing a postdischarge complication (from 4.3% to
6.5%, P ¼ .005). Only 20% of patients (n ¼ 7 of 36) who
died postdischarge experienced an in-hospital complication.
Compared with patients who did not have a postdis-
charge complication, those who experienced a postdis-
charge complication had a more than a sixfold likelihood
of reoperation (3.1% vs 20.4%, respectively; P < .0001)
and death (0.2% vs 3.0%, respectively; P < .0001)
#30 days of surgery. Patients with postdischarge mortality
had a median LOS of 3 days compared with 2 days for
survivors (P ¼ .003). The median LOS was 2 days for
patients with or without a postdischarge complication
(P ¼ .83).
Multivariable analysis for postdischarge mortality.
On multivariable analysis (area under receiver operating
characteristic curve, 0.84), congestive heart failure (odds
ratio [OR], 4.7; 95% conﬁdence interval [CI], 1.0-21.2),
admission from a nursing facility/acute care vs home
(OR, 2.2; 95% CI, 1.5-3.0), increase in age per year
(OR, 1.09; 95% CI, 1.04-1.15), increased anesthesia time
per minute (OR, 1.003; 95% CI, 1.001-1.006), postdis-
charge pneumonia (OR, 28.3; 95% CI, 8.8-91.0), postdis-
charge cardiac arrest/myocardial infarction (OR, 49.2;
95% CI, 12.9-187.4), and postdischarge renal failure
requiring dialysis (OR, 59.0; 95% CI, 10.8-321.3) were
associated with postdischarge 30-day mortality.
Analysis of risk factors for postdischarge mortality.
The 30-day postdischarge death rate amongst patients
admitted from a nursing facility/acute care was 2.5%. In
contrast to patients who survived after EVAR, patients who
died postdischarge were more likely to have been admitted
from a nursing facility/acute care (13.9% vs 1.8%; P <
.0001). The mean 6 standard deviation age of patients
who died postdischarge was higher than those who
survived (79.4 6 7.2 vs 74.1 6 8.5; P ¼ .0002). The
anesthesia time (in minutes) of patients who died post-
discharge was longer than those who survived (269 6 113
vs 227 6 85; P ¼ .0002).
The 30-day postdischarge death among patients who
had postdischarge renal failure was 27% (n ¼ 3 of 11)
and was 19% (n ¼ 4 of 21) among patients who had post-
discharge myocardial infarction, and 14% (n ¼ 6 of 44)
among patients who had postdischarge pneumonia.
Table I. Preoperative characteristics and demographics
Preoperative characteristics
No. (%) or median
(IQR) (N ¼ 11,229)
Cardiac
Angina #1 month 200 (1.8)
Cardiac surgery, prior 2727 (24.3)
Congestive heart failure 127 (1.1)
Myocardial infarction #6 months 111 (1.0)
Percutaneous coronary intervention,
prior
2358 (21.0)
Circulatory
Bleeding disorder 1159 (10.3)
Peripheral arterial disease 595 (5.3)
Rest pain in lower extremity 87 (0.8)
General
Admitted from facility/acute care 201 (1.8)
Age, years 75 (68-80)
ASA class
1 184 (1.6)
2 2437 (21.7)
3 7051 (62.8)
4 1547 (13.8)
5 3 (0.02)
Body mass index, kg/m2 28.4 (25.2-32.2)
Corticosteroid use 430 (3.8)
Diabetes mellitus 1684 (15.0)
Dependent functional status 315 (2.8)
Hypertension 8968 (79.9)
Open wound 95 (0.8)
Race
American Indian 25 (0.2)
Asian/Paciﬁc Islander 162 (1.5)
Black 412 (3.7)
Hispanic 199 (1.8)
Unknown 809 (7.3)
White 9489 (85.5)
Sex
Male 9271 (82.7)
Female 1936 (17.3)
SIRS, preoperative 81 (0.7)
Weight loss >10% #6 months 147 (1.3)
Laboratory
Creatinine
Abnormal 1578 (14.3)
Normal 9279 (84.0)
Unknown 184 (1.7)
Hematocrit
Abnormal 1806 (16.4)
Normal 9031 (81.8)
Unknown 206 (1.9)
Neurologic
Stroke with neurologic deﬁcit 345 (3.1)
Stroke without neurologic deﬁcit 570 (5.1)
Transient ischemic attack 745 (6.6)
Renal
Dialysis (preoperative) 110 (1.0)
Respiratory
Chronic obstructive pulmonary
disease
2126 (18.9)
Dyspnea
At rest 179 (1.6)
On moderate exertion 2496 (22.2)
Social
Alcohol intake within last 2 weeks 495 (4.4)
Smoking within past year 3279 (29.2)
Table I. Continued.
Preoperative characteristics
No. (%) or median
(IQR) (N ¼ 11,229)
Therapy
Anesthesia
General 9383 (83.6)
Regional 1846 (16.4)
Conﬁguration
Unibody 1191 (10.6)
Bifurcated 10,038 (89.4)
LOS, days 2 (1-3)
Operative time, minutes 139 (107-182)
Time under anesthesia, minutes 212 (170-262)
ASA, American Society of Anesthesiologists; IQR, interquartile range; LOS,
length of stay; SIRS, systemic inﬂammatory response syndrome.
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On multivariable analysis (area under the receiver operating
characteristic curve, 0.61), female gender (OR, 1.5; 95%
CI, 1.2-1.9), previous peripheral arterial revasculariza-
tion/amputation (OR, 1.5; 95% CI, 1.1-2.2), previous
cardiac surgery (OR, 1.3; 95% CI, 1.1-1.6), bleeding
disorder (OR, 1.3; 95% CI, 1.0-1.8), diabetes (OR, 1.3;
95% CI, 1.0-1.7), smoking within the last 1 year (OR,
1.3; 95% CI, 1.0-1.6), increase in age per year (OR,
1.02; 95% CI, 1.01-1.03), and operative time (OR,
1.002; 95% CI, 1.001-1.004) were associated with postdis-
charge 30-day morbidity.
Analysis of risk factors for postdischarge morbidity.
Women had a postdischarge overall complication rate of
6.1% in contrast to 4.1% for men (P < .0001). This was
mostly driven by the higher postdischarge wound infection
rate (2.8% vs 1.6%, P < .0001) in women. Patients with
history of peripheral arterial disease also had signiﬁcantly
higher postdischarge complications (7.1% vs 4.3%; P ¼
.001) after EVAR, with this also correlating with more
wound infections (3.2% vs 1.7%, P ¼ .01). A previous
cardiac surgery also predisposed toward a higher overall
postdischarge complication rate (5.3% vs 4.2%; P ¼ .007),
with this driven primarily by postdischarge wound infec-
tions (2.2% vs 1.7%; P ¼ .04) and postdischarge cardiac
complications (0.3% vs 0.1%; P ¼ .047). Postdischarge
wound infections were more common in smokers (2.3%
vs 1.6%; P ¼ .02) and diabetic patients (2.8% vs 1.7%;
P ¼ .001).
DISCUSSION
To our knowledge, this is the ﬁrst population-based,
multicenter registry study that analyzes postdischarge
complications after EVAR. Although overall morbidity
and mortality were relatively low, at 10.7% and 1.0%,
respectively, >30% of these were subsequent to discharge.
Most of the wound, urinary tract, and lung infections
occurred in patients after leaving the hospital. Postdis-
charge cardiac and renal complications were relatively less
Table II. Outcome and timing of in-hospital and postdischarge complications after endovascular aneurysm repair (EVAR)
Event
Time to
event, days,
median (IQR)
In-hospital
event rate,
No. (%)
Postdischarge
event rate,
No. (%)
30-day
event rate,
No. (%)
Events that occurred
between discharge
and 30 days, %
Deatha 9 (3-19) 81 (0.7) 36 (0.3) 117 (1.0) 31
Overall morbidity 3 (1-13) 748 (6.7) 500 (4.5) 1204 (10.7) 40.1
Renal failure requiring dialysis 1 (1-1) 73 (0.7) 11 (0.1) 84 (0.8) 13
Cardiac arrest or myocardial infarction 2 (1-5) 101 (0.9) 21 (0.2) 122 (1.1) 17
Wound infections 16 (11-22) 29 (0.3) 205 (1.8) 234 (2.1) 87.6
Urinary tract infection 8 (3-15) 77 (0.7) 101 (0.9) 178 (1.6) 56.7
Pneumonia 5 (3-12) 89 (0.8) 44 (0.4) 133 (1.2) 33
Venous thromboembolism 8 (2-16) 29 (0.3) 36 (0.3) 65 (0.6) 55
Stroke 4 (1-11) 31 (0.3) 12 (0.1) 43 (0.4) 28
IQR, Interquartile range.
aOverall morbidity refers to any of wound infection, organ space infection, urinary tract infection, wound dehiscence, pneumonia, reintubation, pulmonary
embolism, deep venous thrombosis, failure to wean from ventilator #48 hours, renal insufﬁciency, renal failure requiring dialysis, stroke, coma, peripheral
nerve deﬁciency, cardiac arrest, myocardial infarction, graft complication, transfusion >4 units of red blood cells, and sepsis.
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associated with 30-day mortality. These data highlight
the need of a focused effort to improve postdischarge
care for further improvement in outcomes and to prevent
readmissions.
Interestingly, 91% of patients who developed postdis-
charge complications did not experience a complication
in the inpatient setting. Similarly, only 20% of patients
(n ¼ 7 of 36) who died postdischarge experienced an in-
hospital complication. This suggests that close follow-up
of only those patients who develop in-hospital complica-
tions may not be enough to further improve postdischarge
outcomes.
We found a strong correlation between postdischarge
mortality after EVAR and admission from a nursing
facility/acute care vs home. These patients are generally
frail and are discharged back to their facility. It has been
previously shown that discharge to a skilled nursing facility
is associated with poorer postoperative outcomes.9
Advanced age and congestive heart failure were also associ-
ated with postdischarge mortality. It is interesting to note
that there was no signiﬁcant association of preoperative
comorbidities or postoperative in-hospital complications
with postdischarge mortality. In contrast, postdischarge
cardiac, renal, and pulmonary complications were strongly
associated with postdischarge mortality.
Although women accounted for 17% of the patient
cohort, they had a higher risk of postdischarge complica-
tions then men. Patients with history of peripheral arterial
disease or previous cardiac surgery, smokers, and diabetic
patients also had higher overall postdischarge morbidity,
mostly driven by higher postdischarge wound infection
rates. Prolonged operative time was also associated with
higher postdischarge morbidity, as shown previously in
general surgery.10 In contrast to general surgery, in-
hospital complications were not signiﬁcantly associated
with postdischarge complications after EVAR.10 This is
probably due to the short median hospital LOS after EVAR.Patients undergoing EVAR are usually followed up at
2 weeks for wound evaluation or at 1 month with
computed tomographic imaging.2 The median occur-
rence for most of the postdischarge complications in the
present study was within the ﬁrst 10 days after surgery.
The interquartile range was 11 to 22 days for the diag-
nosis of a wound infection after EVAR. These data
suggest that earlier follow-up of high-risk patients may
help identify and possibly prevent some of these complica-
tions and subsequently decrease readmissions, as shown in
a previous study.11 Similarly, another study12 reported
dedicated nurse practitioner involvement increased tele-
phone communication by 64% with discharged patients
and also enabled more patients to be sent home with
nursing, physical therapy, and occupational therapy
services, thereby decreasing emergency room visits and
readmissions. Our study highlights the need for a stan-
dardized protocol for triage and surveillance of high-risk
patients post-EVAR to further improve postoperative
outcomes. Coordinated care programs such as the Transi-
tion Care Model (TCM), Re-Engineered Discharge
(RED) program, Care Transitions Intervention (CTI),
and Care Transitions Program for Medicare beneﬁciaries
may be helpful for targeting high-risk patients.13-16
Despite the strengths of the study due to the use of
a multicenter, clinically validated data set, there are some
limitations. It is possible that despite controlling for
multiple preoperative variables in the multivariable analysis,
we may have missed some confounders such as socioeco-
nomic status and hospital-level and region-level variation.
We did not control for femoral cutdown vs a percutaneous
approach because this relies on femoral cutdown being
coded along with EVAR and this may be missed if not
present in the operative dictation. The timing of reoperation
is not speciﬁed in NSQIP; thus, it could be a predischarge
event or occur on readmission. Data on readmission are
also not available from the 2005 to 2010 NSQIP data
sets. Lastly, although the data were prospectively collected,
JOURNAL OF VASCULAR SURGERY
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tional study, causality could not be determined.
CONCLUSIONS
A third of deaths and complications after EVAR are
postdischarge. Patient characteristics associated with a
higher risk for postdischarge adverse events after EVAR
were identiﬁed. Whether improved predischarge surveil-
lance and close postdischarge follow-up of identiﬁed
high-risk patients will further improve 30-day outcomes
after EVAR needs to be prospectively studied.
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Kent’s group had found that one of the most common reasons for
readmissions following open and endovascular abdominal aortic
aneurysm repairs was wound complications. So this to me is
another reason to consider percutaneous interventions. Do you
have data on this data set on how many of these patients with
wound complications were done percutaneously and how many
had open femoral exposure? In that paper, 46% were percutaneous,
and this study is on a more recent time period.
Dr Prateek K. Gupta. National Surgical Quality Improve-
ment Program (NSQIP) is essentially based on Current Procedural
Terminology (CPT) codes for procedures. While there are CPT
codes for femoral cutdowns, there are no codes for a percutaneous
approach. Thus, we deliberately excluded looking at patients for
percutaneous vs a cutdown approach, as many times that particular
approach might not have been coded for, resulting in a coding
error and possibly false results due to that.
Dr Matthew Mell (Stanford, Calif). My question is about
patient selection. It is sobering that a third of early deaths afterelective operations occurred outside of the hospital, and I wonder
if you could comment on the contribution of marginal patients to
this observation.
Dr Gupta. We see that the event rate for death is pretty
low, it is around 1%, and it has gradually gotten better over the
last decade. However, as you said, a third of these are after
discharge. The study does identify the patients who are at high-
risk after the operation, and focusing on these patients may
improve patient selectiondand thus outcomes.
Dr Anton Sidawy (Washington, DC). I would just like to
point out that this 30% postdischarge complication rate is not
only limited to EVAR. We presented a few years ago at the
Vascular Annual Meeting the results of the Society for Vascular
Surgery Carotid Registry, and in both open carotid endarterec-
tomy and carotid angioplasty and stenting, we had a postdischarge
complication rate of about 25% to 30% up to 30 days. Since we are
encountering this in different areas of vascular surgery, maybe we
should double our efforts to ﬁgure out how we can predict which
patient is going to have a complication after discharge.
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tions that have relatively shorter hospital length of stay, we are
seeing most of the complications occurring postdischarge. Maybe
the follow-up protocols for these should be different compared
to the open operations where patients stay in-house for a longer
duration before they go home.
Dr Thomas Riles (New York, NY). I noticed that one of the
pre-op risk factors was not renal failure, but you had so manypeople die of renal failure post-op. Can we presume that those
renal complications resulted from the surgery?
Dr Gupta. Yes, those renal complications resulted from the
surgery. We did speciﬁcally look for preoperative renal failure
and controlled that using interactions; however, for this particular
cohort, preoperative chronic renal failure requiring dialysis was not
associated with postdischarge mortality or morbidity. Being all
elective patients, preoperative acute renal failure was excluded.
